Summary
Updated Aug 31, 2026
Gerald T. Proehl is PRESIDENT, CHAIRMAN, CEO, Director, 10% Owner of Dermata Therapeutics, Inc. (DRMA). 5 SEC Form 4 filings on record going back to 2024, most recently on 18 August 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Gerald T. Proehl has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Gerald T. Proehl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Munera Maria E. Bedoya-Toro - $1K of DRMA open-market activity in the last 12 months
- Kathleen D. Scott - $13 of DRMA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gerald T. Proehl?
Gerald T. Proehl is a corporate insider, tracked as PRESIDENT, CHAIRMAN, CEO, Director, 10% Owner of Dermata Therapeutics, Inc. (DRMA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gerald T. Proehl submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Gerald T. Proehl's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gerald T. Proehl and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
